Inactivation of the NLRP3 inflammasome mediates exosome-based prevention of atrial fibrillation.

Authors:
Parent S; Vaka R; St Amant J; Kahn S; Van Remortel S and 4 more

Journal:
Theranostics

Publication Year: 2024

DOI:
10.7150/thno.89520

PMCID:
PMC10758048

PMID:
38169629

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Theranostics

Abbreviation: Theranostics

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Diagnostic Imaging

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
20-HETE mediated TRPV1 activation drives allokinesis via MrgprA3<sup>+</sup> neurons in chronic der…
Yu G; Liu P; Huang X and 11 more (2024) - Transparency Score: 3/6
Activatable prodrug for controlled release of an antimicrobial peptide via the proteases overexpres…
Amer L; Retout M; Jokerst JV. (2024) - Transparency Score: 3/6
Annotation of CD8<sup>+</sup> T-cell function via ICAM-1 imaging identifies FAK inhibition as an ad…
Zhang T; Zhang Y; Zhao Y and 11 more (2024) - Transparency Score: 3/6
A novel approach to guide GD2-targeted therapy in pediatric tumors by PET and [<sup>64</sup>Cu]Cu-N…
Trautwein NF; Schwenck J; Seitz C and 12 more (2024) - Transparency Score: 3/6
Antibacterial micro/nanomotors: current research progress, challenges, and opportunities.
Liu XY; Li RF; Jia J and 1 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Competing Interests: SP and DRD are co-inventors for a patent application submitted regarding extracellular vesicle treatment of atrial fibrillation (US patent filing number 63/278,518). DC, DJS and DRD hold a patent regarding serum-free and xenogen-free human cardiac explant-derived stem cells (US patent 11083756)."

Evidence found in paper:

"This work was supported by the Canadian Institutes of Health Research (Project Grant 410103) and the Natural Sciences and Engineering Research Council of Canada (CHRPJ 549626-20 and I2IPJ 581202-23)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025